Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. (IIH:DT)

Clinical Trial ID NCT02017444

PubWeight™ 1.55‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02017444

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 2016 0.84
2 Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases. J Pain Res 2016 0.75
Next 100